1 (Image 1)
Bexarotene Capsule, Liquid Filled
Product Images NDC 0591-2832
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bexarotene (NDC 0591-2832). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
1 (Image 2)
This is a description of Bexarotene capsules, with a dosage of 75mg per capsule. Patients are instructed to read accompanying information carefully. The package insert contains complete preparing information, and the medication should be stored at a temperature between 20-25°C to protect it from light and high temperatures and humidity. The medication is manufactured by Teva Pharmaceuticals USA, Inc. and this is the NDC number 0591-2832-01.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
